Press Releases Sanofi

Equities

SAN

FR0000120578

Pharmaceuticals

Real-time Euronext Paris Other stock markets 12:51:07 18/06/2025 BST			5-day change	1st Jan Change
83.54 ^EUR	-1.54%		-4.49%	-10.88%

05-30	Healthcare Stocks Rise -- Healthcare Roundup	DJ
05-30	Sector Update: Health Care Stocks Advance Late Afternoon	MT

Press Releases

Press release: Sanofi successfully prices €1.5 billion bond issue	06-17	GL
Sanofi: Disclosure of trading in own shares	06-17	PU
SNY Investors Have Opportunity to Join Sanofi Fraud Investigation with the Schall Law Firm	06-16	BU
Sanofi - EAACI, Dupixent demonstrated superiority over Xolair in chronic rhinosinusitis with nasal polyps in patients with coexisting asthma in first-ever presented phase 4 head-to-head respiratory study	06-16	AQ
Press Release: EAACI: Dupixent demonstrated superiority over Xolair (omalizumab) in chronic rhinosinusitis with nasal polyps in patients with coexisting asthma in first-ever presented phase 4 head-to-head respiratory study	06-15	PU
Press Release: EAACI: Dupixent demonstrated superiority over Xolair (omalizumab) in chronic rhinosinusitis with nasal polyps in patients with coexisting asthma in first-ever presented phase 4 head-to-head respiratory study	06-15	GL
Sanofi: Informations relatives au nombre de droits de vote et d'actions - Mai 2025	06-09	PU
Sanofi Appoints James Guy as Country Lead, Canada and General Manager, Specialty Care	06-09	AQ
Press Release: Sanofi accelerates global shipping of Beyfortus to prepare healthcare providers months ahead of 2025-2026 RSV season	06-09	GL
Media Update: RAD: Dupixent data reinforce use in atopic dermatitis patients with skin of color	06-07	PU
Sanofi: Disclosure of trading in own shares	06-06	PU
Media Update: ISTH: new data highlight innovation from Sanofi’s pipeline in rare diseases	06-06	PU
Press release: Sanofi Launches 2025 Global Employee Stock Purchase Plan	06-05	GL
Press Release: ASCO: new Sarclisa data support subcutaneous administration with on-body injector	06-03	PU
Press Release: ASCO: new Sarclisa data support subcutaneous administration with on-body injector	06-03	GL
Press Release: Rilzabrutinib granted orphan drug designation in the US for sickle cell disease	06-03	GL
Sanofi acquires Blueprint Medicines for $9.1 billion	06-02	AQ
Federal Court Affirms HRSA Authority To Preapprove 340B Rebate Models But Urges HRSA To Reconsider Rejection Of Rebate Model	06-02	AQ
Sanofi to acquire Blueprint Medicines, expanding portfolio in rare immunological disease and adding early-stage pipeline in immunology	06-02	PR
Press Release: Sanofi to acquire Blueprint Medicines, expanding portfolio in rare immunological disease and adding early-stage pipeline in immunology	06-02	GL
Press Release: Sanofi to acquire Blueprint Medicines, expanding portfolio in rare immunological disease and adding early-stage pipeline in immunology	06-02	GL
Press Release: Itepekimab met the primary endpoint in one of two COPD phase 3 studies	05-30	GL
Imperial College London.: The future of AI-powered healthcare showcased in San Francisco	05-29	AQ
Press Release: Beyfortus public health advantage bolstered by first real-world comparison of infant vs maternal RSV immunization programs	05-29	GL
FDA Approves BLA For Novavax's COVID-19 Vaccine	05-27	AQ